{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:34:16Z","timestamp":1740180856584,"version":"3.37.3"},"reference-count":16,"publisher":"Consilium Medicum","issue":"3","license":[{"start":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T00:00:00Z","timestamp":1713225600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Bronchial asthma and chronic polypous rhinosinusitis are diseases associated with a T2-inflammatory immune response. These nosologies can be combined, creating the preconditions for a more severe course of multimorbidity, requiring the use of genetic engineering biological therapy. Dupilumab is a monoclonal antibody that can specifically bind to the alpha subunit of the interleukin-4 receptor and block the action of interleukins 4 and 13, which play a key role in the development of T2 inflammation. Numerous studies have demonstrated the high effectiveness of this medicament. The use of dupilumab in some cases may be accompanied by an increase in eosinophils in the blood. This article presents scientific base and our own experience in treating patients with dupilumab-associated eosinophilia, in addition we describe an algorithm for examining this group of patients for the purpose of timely diagnosis of diseases such as eosinophilic granulomatosis with polyangiitis, eosinophilic pneumonia, etc. It should be noted that in the most cases eosinophilia during targeted therapy with dupilumab is temporary and does not cause clinical manifestations.<\/jats:p>","DOI":"10.26442\/00403660.2024.03.202650","type":"journal-article","created":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T19:05:29Z","timestamp":1713294329000},"page":"303-308","source":"Crossref","is-referenced-by-count":0,"title":["Blood eosinophilia in patients with severe bronchial asthma and chronic polypous rhinosinusitis treated with dupilumab: A review"],"prefix":"10.26442","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5103-2446","authenticated-orcid":false,"given":"Anna Yu.","family":"Petukhova","sequence":"additional","affiliation":[{"name":"Central City Clinical Hospital No. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-5345-7510","authenticated-orcid":false,"given":"Aleksey S.","family":"Gromov","sequence":"additional","affiliation":[{"name":"Central City Clinical Hospital No. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5821-4340","authenticated-orcid":false,"given":"Robert V.","family":"Solovyov","sequence":"additional","affiliation":[{"name":"Central City Clinical Hospital No. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3066-8609","authenticated-orcid":false,"given":"Svetlana G.","family":"Filippova","sequence":"additional","affiliation":[{"name":"Central City Clinical Hospital No. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7139-0725","authenticated-orcid":false,"given":"Elmira R.","family":"Prokopieva","sequence":"additional","affiliation":[{"name":"Central City Clinical Hospital No. 6"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"18344","published-online":{"date-parts":[[2024,4,16]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2022.05.019"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2022.07.201713"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4193\/Rhin20.600"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.anai.2020.03.004"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S52387"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.03.030"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.26442\/00403660.2023.07.202309"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00322-2"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2024.2304556"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804093"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Shinkai A, Yoshisue H, Koike M, et al. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. J Immunol. 1999;163(3):1602-10","DOI":"10.4049\/jimmunol.163.3.1602"},{"key":"ref14","unstructured":"Yoshifuku K, Matsune S, Ohori J, et al. IL-4 and TNF-alpha increased the secretion of eotaxin from cultured fibroblasts of nasal polyps with eosinophil infiltration. Rhinology. 2007;45(3):235-41."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.14488"},{"key":"ref16","unstructured":"Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. Available at: https:\/\/ginasthma.org\/2023-gina-main-report. Accessed: 02.12.2023."}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/630183\/pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/630183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T08:58:48Z","timestamp":1733216328000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/630183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,16]]},"references-count":16,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2024,4,16]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2024.03.202650","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"type":"electronic","value":"2309-5342"},{"type":"print","value":"0040-3660"}],"subject":[],"published":{"date-parts":[[2024,4,16]]}}}